Abnormalities, Drug-Induced: Clinical Trials

2 trials for Abnormalities, Drug-Induced, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Abnormalities, Drug-Induced: new trials by email Literature Review of Abnormalities, Drug-Induced trials Research Report on Abnormalities, Drug-Induced

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University732021-09-022026-10-20
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
Progesterone, Ibutilide - Long QT Syndrome, Abnormalities, Drug-Induced
Phase 4CompletedIndiana University272019-03-262025-07-01

Narrower conditions

Long QT Syndrome (2)

Broader conditions

Arrhythmias, Cardiac (2)  ·  Cardiac Conduction System Disease (2)  ·  Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Progesterone (2)  ·  ibutilide (2)  ·  Testosterone (1)

Sponsors

Indiana University (2)

Countries

United States (2)

Top investigators

James E Tisdale, PharmD (2)

NIH funding

R01HL153114 (1)